Failure of the Merck HIV vaccine: an uncertain ste...[Lancet. 2008] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: Lancet. 2008 Nov 29;372(9653):1857-8. Epub 2008 Nov 13. Links

Comment on:: Lancet. 2008 Nov 29;372(9653):1881-93.

Failure of the Merck HIV vaccine: an uncertain step forward.

US Military HIV Research Program, Rockville, MD 20850, USA. mrobb@hivresearch.org

PMID: 19012958 [PubMed - indexed for MEDLINE]

Related articles

AIDS vaccine may offer hope only for some ethnic groups.
BMJ. 2003 Mar 1; 326(7387):463.

[BMJ. 2003]
HIV vaccine failure prompts Merck to halt trial.
Nature. 2007 Sep 27; 449(7161):390.

[Nature. 2007]
HIV vaccine fails in phase 3 trial.
Lancet. 2003 Mar 1; 361(9359):755-6.

[Lancet. 2003]
ReviewPost-step modifications for research on HIV vaccines.
AIDS. 2009 Jan 2; 23(1):3-8.

[AIDS. 2009]
ReviewHIV vaccine trial results are an important step forward in developing an effective vaccine, say WHO and UNAIDS.
J Adv Nurs. 2003 Jul; 43(2):116.

[J Adv Nurs. 2003]
» See reviews... | » See all...

Recent Activity

Clear Turn Off Turn On

Failure of the Merck HIV vaccine: an uncertain step forward.Failure of the Merck HIV vaccine: an uncertain step forward.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show